Form D — Incyclix Bio, LLC
0001916275-25-000001 · filed Aug 22, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $20,000,000
- Reported amount sold
- $11,249,977
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Incyclix Bio, LLC
- CIK
- 1916275
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 600 PARK OFFICES DRIVE
Durham, North Carolina 27713 - Phone
- (919) 328-0003
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Patrick Roberts · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
Fredric N. Eshelman · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
Norman Sharpless · DirectorDurham, North Carolina Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗